SCHEMBL12422004

SCHEMBL12422004

Cc1ccc2nc(-c3ccc(NC(=O)c4ccc(N)cc4C)cc3)sc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.63
TP53 P04637 4/20 0.63
KDM4E B2RXH2 7/20 0.61
NPC1 O15118 7/20 0.61
RAB9A P51151 7/20 0.61
APP P05067 3/20 0.61
GLA P06280 1/20 0.61
GAA P10253 1/20 0.61
LMNA P02545 2/20 0.61
SMN1; SMN2 Q16637 5/20 0.60
ALDH1A1 P00352 5/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
CASP3 P42574 1/20 0.60
SENP8 Q96LD8 1/20 0.60
SENP7 Q9BQF6 1/20 0.60
SENP6 Q9GZR1 1/20 0.60
HPGD P15428 3/20 0.59
NPSR1 Q6W5P4 2/20 0.59
RXFP1 Q9HBX9 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2192742 0.88 MAPT (0.73) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL6227082 0.86 MAPT (0.76) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL12422006 0.86 APP (0.63) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL12422193 0.86 MAPT (0.67) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL2193235 0.84 MAPT (0.73) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL12422008 0.84 MAPT (0.59) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL12980051 0.84 MAPT (0.67) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL1071608 0.84 MAPT (0.67) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL1071610 0.84 MAPT (0.67) MAPTTP53KDM4ENPC1RAB9A
SCHEMBL12422021 0.84 SULT1A1 (0.72) MAPTTP53KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES MAPT, PRNP, MAP4 MAPT 1/4885TP53 94/4885KDM4E 4073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.